Safety and Efficacy of PCI at California Hospitals Without Onsite Cardiac Surgery
PCI-CAMPOS
PCI California Audit Monitored Pilot With Offsite Surgery
1 other identifier
interventional
5,609
1 country
6
Brief Summary
To evaluate the introduction of Percutaneous Coronary Intervention without Onsite Surgery in the largest state, California (CA) began a pilot PCI program in 6 hospitals without onsite cardiac surgery and then compared the PCI results in the pilot hospitals with results in 120 non-pilot hospitals. The pilot program qualification incorporated appropriate planning and rigorous hospital, operator, patient, and lesion selection criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable coronary-artery-disease
Started Aug 2010
Typical duration for not_applicable coronary-artery-disease
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 17, 2013
CompletedFirst Posted
Study publicly available on registry
December 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedMay 30, 2017
May 1, 2017
4.3 years
December 17, 2013
May 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite safety endpoint (death, stroke, need for emergent CABG)
The number of subjects who had death, stroke or a need emergent CABG as a result of having PCI procedure performed.
participants will be followed for the duration of hospital stay, an expected average of 3 days.
Secondary Outcomes (2)
Composite efficacy endpoint (<20% residual stenosis and post TIMI-3 flow)
participants will be followed for the duration of hospital stay, an expected average of 3 days.
AOC composite endpoint (in-hospital death and/or need for emergent CABG)
participants will be followed for the duration of hospital stay, an expected average of 3 days.
Other Outcomes (5)
In-hospital death
participants will be followed for the duration of hospital stay, an expected average of 3 days.
Stroke
participants will be followed for the duration of hospital stay, an expected average of 3 days.
Need for emergent CABG
participants will be followed for the duration of hospital stay, an expected average of 3 days.
- +2 more other outcomes
Study Arms (2)
PCI at pilot hospitals
ACTIVE COMPARATORPercutaneous Coronary Interventions performed at pilot hospitals which do not have onsite cardiac surgery.
PCI at non-pilot hospitals
ACTIVE COMPARATORPercutaneous Coronary Intervention performed at non-pilot hospitals which have onsite cardiac surgery or perform only primary PCIs for STEMI patients.
Interventions
Eligibility Criteria
You may qualify if:
- clinically and angiographically significant coronary artery disease
- ability to perform PCI with equipment available at the local site
- not high-risk patient with a not high-risk lesion
- not high-risk patient with a high-risk lesion
- high-risk patient with a not high-risk lesion may be included in the pilot program upon confirmation that a cardiac surgeon and an operating room are immediately available if necessary
You may not qualify if:
- high-risk patient with a high-risk lesion
- need for coronary artery bypass surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- Clovis Community Hospitalcollaborator
- Doctors Medical Centercollaborator
- Kaiser Permanentecollaborator
- Los Alamitos Medical Centercollaborator
- St. Rose Hospitalcollaborator
- Sutter Roseville Medical Centercollaborator
Study Sites (6)
Clovis Community Medical Center
Clovis, California, 93611, United States
St Rose Hospital
Hayward, California, 94545, United States
Los Alamitos Medical Center
Los Alamitos, California, 90720, United States
Sutter Roseville Medical Center
Roseville, California, 95661, United States
Doctors Medical Center
San Pablo, California, 94806, United States
Kaiser Foundation Hospital Walnut Creek
Walnut Creek, California, 94596, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William J Bommer, MD
UC Davis Health System
- PRINCIPAL INVESTIGATOR
Rohit Sundrani, MD
Clovis Community Medical Center
- PRINCIPAL INVESTIGATOR
Stephen Arnold, MD
Doctors Medical Center, San Pablo
- PRINCIPAL INVESTIGATOR
Sushil Karmarkar, MD
Kaiser Permanente
- PRINCIPAL INVESTIGATOR
Steven Forman, MD
Los Alamitos Medical Center
- PRINCIPAL INVESTIGATOR
Aditya Jain, MD
St Rose Hospital, Hayward
- PRINCIPAL INVESTIGATOR
George Fehrenbacher, MD
Sutter Roseville Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2013
First Posted
December 27, 2013
Study Start
August 1, 2010
Primary Completion
December 1, 2014
Study Completion
February 1, 2015
Last Updated
May 30, 2017
Record last verified: 2017-05